NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 215 filers reported holding NEVRO CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $812,372 | -16.5% | 42,267 | +10.4% | 0.01% | -16.7% |
| Q2 2023 | $972,849 | -36.7% | 38,271 | -10.0% | 0.01% | -33.3% |
| Q1 2023 | $1,536,411 | -5.2% | 42,501 | +3.8% | 0.01% | 0.0% |
| Q4 2022 | $1,621,026 | -36.7% | 40,935 | -25.5% | 0.01% | -30.8% |
| Q3 2022 | $2,559,000 | +6.5% | 54,915 | +0.2% | 0.01% | +30.0% |
| Q2 2022 | $2,402,000 | -31.9% | 54,810 | +12.5% | 0.01% | -28.6% |
| Q1 2022 | $3,525,000 | +17.2% | 48,735 | +31.4% | 0.01% | -17.6% |
| Q4 2021 | $3,007,000 | -20.1% | 37,092 | +14.7% | 0.02% | -19.0% |
| Q3 2021 | $3,763,000 | -34.7% | 32,334 | -7.0% | 0.02% | -43.2% |
| Q2 2021 | $5,765,000 | – | 34,773 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |